When Will the Big Canadian Cannabis Producers Become Profitable?

How long will it take for Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) and others to reach profitability?

| More on:
question marks written reminders tickets

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The cannabis industry hasn’t exactly been the most fun to watch as of late. With a market downturn already in the works, investors are a lot more wary to put their money into these companies that still have a lot to prove.

The number one thing each has to prove? That it can produce profit. There have been a few out there that have managed the task already, but what many investors are likely wondering is when the bigger companies will come out with some profits.

With that in mind, let’s look at the top three Canadian cannabis producers by production capacity and see when it’s likely that investors could see profits. Because when each posts a profit, shares should finally get back to normal.

Canopy Growth

It’s no secret that things have been difficult for Canopy Growth Corp. (TSX:WEED)(NYSE:CGC). After ousting former-CEO and founder Bruce Linton, the company posted an incredible net loss of $2.28 billion in its latest earnings report.

Despite this mainly being due to the extinguishing of warrants from partner Constellation Brands, shares in the company has dipped lower and lower, reaching levels not witnessed since April of 2018.

The company is still optimistic that it will hit revenue of $1 billion in the next year, and is on the way with sales and production growing at a rapid rate. But as for profitability, investors will have to wait longer while the company uses that cash to pay down this significant amount of debt.

According to analysts, it could be as late as 2024 before the company posts a profit, and 2022 at the earliest.

Aurora Cannabis

Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) is in a slightly better position, as the company doesn’t have either a partner or significant debts to deal with. What it does have to deal with, however, is its effect on investors after diluting shares to pay for its projects.

While the company has set itself up to be the number one cannabis producer in the world by June 2020, with 625,000 kilograms produced per year, it has a long way to go to gain back investor trust.

Much of that trust should come back if the company can bring in profits to drive up shares again. The company is trading near share prices not seen since before the new year, so positive earnings reports likely won’t cut it until this company can prove it’s on the path to profits.

Even with a positive fourth-quarter report coming up in mid-September, the company still likely won’t see profitability until at least June 2021.

Aphria

So you’d think that I’m on a pretty negative path, but then there’s Aphria Inc. (TSX:APHA)(NYSE:APHA). Aphria was the only mega producer to post a profit, shocking analysts and investors alike during its last earnings report.

After a series of scandals tanked shares, the company saw a jump of over 30% when the news broke of Aphria bringing in net income of $15.8 million.

However, a lot of this was due to the acquisition of CC Pharma, a German medical marijuana and pharmaceutical company with a foothold in a number of European countries, so it’s not exactly from anything that Aphria is doing.

Still, that’s profit before its other mega peers, leaving investors to think that as the company continues to grow — both organically and inorganically — there could be far more profits in this company’s future.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns shares of Aurora Cannabis and Canopy Growth.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »